A Study of Galiximab + Rituximab Versus Rituximab + Placebo in Follicular Non-Hodgkin's Lymphoma (NHL)

Clinical trial NCT00363636 · TERMINATED

Trial details

NCT number: NCT00363636
Sponsor: Biogen
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Lymphoma, Non-Hodgkin's

Start date: 2006-09-01
Primary completion: 2010-01-01
Enrollment: 340

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.